Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;25(1):104-105.
doi: 10.5005/jp-journals-10071-23709.

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge

Jay Prakash  1 , Pradip K Bhattacharya  1 , Shio Priye  2 , Naveen Kumar  3
Affiliations

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge

Jay Prakash et al. Indian J Crit Care Med. 2021 Jan.

Abstract

How to cite this article: Prakash J, Bhattacharya PK, Priye S, Kumar N. Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge. Indian J Crit Care Med 2021;25(1):104-105.

Keywords: Consequences; Coronavirus disease 2019; Pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Figs 1A and B
Figs 1A and B
HRCT showing patchy opacities with small areas of ground-glass opacities and fibrotic bands seen predominantly in the periphery of both lungs with apicobasal gradient
See this image and copyright information in PMC

References

    1. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int https://covid19.who.int
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585. DOI: - DOI - PMC - PubMed
    1. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750–752. doi: 10.1016/S2213-2600(20)30222-8. DOI: - DOI - PMC - PubMed
    1. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815. doi: 10.1016/S2213-2600(20)30225-3. DOI: - DOI - PMC - PubMed
    1. Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol. 2001;99(3):308–319. doi: 10.1006/clim.2001.5008. DOI: - DOI - PubMed

LinkOut - more resources